Our rules relevant to these genes revealed that Zyxin, MGST1, APLP2, and ARHG are upregulated in AML, while TCRA, CCND3, HKR-T1, KIAA0159, TOP2B, MB-1, and IOTA are upregulated in ALL. This evidence concerns the gene CD79A and acute myeloid leukemia.